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Introduction

infection with enteric infections has not been
established.

Early weaning programs have been aimed
at the control and elimination of respiratory
infections in the young pig. Segregation from
their dams at less than 21 .days, batch rearing
with all-in all-out by room, building, or site, and
proper biosecurity (cleaning, disinfecting and
quarantine) are mandatory to implement early
weaning programs 1. Early weaning with all its
components gives a tremendous economic
advantage to those who use this technology.
This technology however does not come without
a cost. This requires necessary building sites,
scheduling and a high level of management.
Enteric infections such as neonatal coccidiosis
and post weaning diarrhea problems have not
been prevented by early wean programs.
Although the Pork Quality Assurance Program
has been developed to achieve the highly
desirable goal of reduced antibiotic use, there
are feed and water medication is needed for
prevention and control of enteric infections.
We were interested in the effects of low
levels of conventional water and feed grade
antibiotic treatments on performance and
immunological parameters of the young pig
infected with the common enteric pathogens, E.
coli and rotavirus. Previously, we had tested
this treatment at both a research facility and a
commercial operation and had shown increased
production and decreased immunological
response in the treated animals 2·3 • We have
established that the use of such a program
would be a benefit to those producers who do
not have the production facilities that would
allow early weaning (7-10 days) and/or multi-site
production. However the effect of these oral
treatments on minimizing production losses and
activation of the immune system following
1
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The purpose of this study was to measure
production and immunological parameters in
orally medicated and control animals following a
post weaning E. coli and rotavirus challenge.
Experimental Procedure
Animals and Management
Farrowing and neonatal pig management: A
commercial 130-head sow herd of known health
status was chosen for this trial. This is a herd
whose health status is monitored by Dr. Chase.
The farrowing facility is a two-year-old building
with 2-10 crate rooms. Pigs were processed at
1 day of age (tails removed, iron dextran
injections, needle teeth clipped). The pigs were
vaccinated for Mycoplasma hyopneumoniae at
7-11 days of age and the boars were castrated.
Prior to vaccination on day 7-11, a 3 ml blood
sample was collected. At day 17-21 (weaning
day) the pigs were re vaccinated with M.
hyopneumoniae and a 10 ml heparinized blood
sample were collected from 10 pigs in each
group.

Ten sows (ten litters-92 pigs: 5 litters/group)
were randomly assigned to one of two groups:
1) control and 2) treatment.
The treatment
regimen consisted of feeding 400 g/ton of
Aureomycin™ in the gestation-lactation ration
for 1 week before and 1 week after farrowing.
The baby pigs' water was treated with water
soluble Aureomycin™ to deliver 1O mg/# body
weight beginning day 2 post farrowing through
day 9 post farrowing. Auero-Sulmet™ soluble
was added to the pigs' drinking water at rate of
250 mg chlortetracycline/250 mg sulfamethazine
per gallon from day 10 post farrowing through
day
27-34
post
farrowing
(10
days
postweaning). ASP250™ at a rate of 100 gm
Chlortetracycline/100 gm sulfamethazine/50 gm
penicillin per ton was used in the creep feed.

feces; 2-pudding feces; 3-slightly runny feces;
and 4-watery feces) for 29 days.

Control pigs diets were managed using the
farm's husbandry procedures and all control
creep contained 40 grams/ton of Apralan ™.

Microbiological tests: A fecal sample was
collected using a sterile swab from one pig in
each pen on the day of challenge and 3, 10, 16,
24, 28, and 35 days PC.

The pigs were
weaned at 17-21 days of age and transported
100 miles from Brookings, SD to Beresford, SD
to an newly remodeled nursery-finisher isolation
facility. The nursery facility contained 2 rooms
each room contained 10-6' ft X 16' pens. The 46
treatment and 46 control pigs were each divided
into 8 replicates. Eight pens in one room were
divided with plywood and plastic coated wire
was placed over the slats to prevent injury to the
young pigs. Treated pigs were placed in one
half and control pigs were placed in the other
half of each pen. The treated pigs received
Auero-Sulmet™ soluble in the drinking water at
rate
of
250 mg
chlortetracycline/250 mg
sulfamethazine per gallon for 1O days post
weaning (day 27-34 post farrowing). All the pigs
received traditional phase I, II, & Ill commercial
nursery diets 4 • Diet changes were made at 7
and 21 days post weaning. The treated pigs
nursery diet contained ASP250™ at a rate of
100 gm
chlortetracycline/
100 gm
sulfamethazine/ 50 gm penicillin per ton.
Control pigs weaning diets contained 40
grams/ton of Apralan™. All pigs were switched
to 20 grams/ton of Tylan 1O for the
grower/finisher phase and these diets were
standard grow finish diets. The pigs were
weighed weekly through day 160. All feed was
weighed to obtain feed efficiency data.
Nursery

management:

Bacteriology: The swabs were streaked. by
the SDSU Diagnostic Bacteriology Laboratory
on .differential plates. The number of hemolytic
E. coli was estimated. E.coli isolates were then
typed for 0111.
Virology: The fecal swabs were then pooled
according to treatment groups and the samples
examined with an electron microscope for the
presence of rotavirus by the SDSU Electron
Microscopy Laboratory.
Serology: Blood was collected and serum
samples were harvested at 7-11 and 53-57 days
of age (35 days PC) from 1O pigs in each group.
Serum
samples
were
tested
for
M. hyopneumoniae
antibodies
using
as
commercial
M. hyopneumoniae
ELISA
performed by Oxford Diagnostic Laboratories,
Worthington, MN.
Clinica Jmmuno/ogy:1 O ml-heparinized blood
was collected and lymphocytes harvested at 1721 (weaning day), 23-27 (4 days PC), 30-34 (11
days PC) and 53-59 days of age (34 days PC)
from 10 pigs in each group.
Mitogen
proliferation assays were conducted in the
SDSU Clinical Immunology Laboratory. The
plant lectins, concanavalin A (ConA) at 1 µg/ml,
phytohemagglutinin A (PHA) at 1 µg/ml and
pokeweed mitogen '(PWM) at 5 µg/ml were used
to ·stimulate
isolated
peripheral
blood
lymphocytes. The lymphocytes were cultured
for 44 hours and pulsed for 4 hours with tritiated
(3H) thymidine and harvested at 48 hrs in a cell
collector. The disks were counted in a liquid
scintillation counter. All cultures were done in
triplicate and the values represent the mean
specific
incorporation
(sample
m'eanunstimulated cell mean) of the triplicate
samples.
Forced antibody production was
performed after the protocol of Hammerburg et.
al 5 • Briefly, 1 ml of mononuclear cells at 3 X
106/ml were incubated in 12 X 75 mm sterile
plastic tubes containing 1 ml of RPMI with
1O µg/ml of PWM for 72 hours. The tubes were
centrifuged and the supernatant was collected.
The supernatant was diluted in a ten fold series

Microbiological challenge: Rotavirus (OSU
strain) was obtained from Dr. David Benfield,
Dept. Vet. Sci., South. Dakota State University
(SDSU). The stock virus had been passed
through pigs. The virus was grown on MA104
cells, harvested and titrated. The tier of the
challenge virus was 6.25 X 109 TCID50. The
virus was diluted with minimum essential media
(MEM) to give each pig a 2 ml challenge dose of
107 of TCID50 rotavirus p.o. The 0111 strain of
E.coli was grown in broth cultures and diluted to
250 ml with PBS and each pig was given a 2 ml
dose p.o. that containing 108 E.coli 0111. The
pigs were challenged 2 days after arriving at the
nursery facility (19-23 days of age).
Clinical indices: Clinical sign~ (fever and
diarrhea) were recorded. The temperature of
the same one or two pigs/pen was taken for 15
days. Diarrhea was assessed daily in each pen
on a scale of 0-4 (0-firm, formed feces; 1-pasty
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titers and none of the treated pigs and passive
titers (Table 4).

and a polyclonal-polyclonal sandwich capture
ELISA was used to measure the total amount of
immunoglobulin present.
The assay was
standardized with a preparation of porcine lgG
(Sigma, St. Louis, MO).

Clinical immunology: T cell mitogen activity,
B cell
mitogen
activity
and
induced
immunoglobulin (lg) were measured in the
treatment and control groups (Figures 3-5). The
immunological response with the T cell mitogens
with both phytohemagglutinin (PHA) and
concanavalin A (ConA) was lower in the
treatment group (Figure 3). The ConA response
was significantly lower (P<0.05) at 17, 30 and 56
days of age (Figure 3).
The B and T cell
mitogen pokeweed mitogen (PWM) (Figure 4)
and the forced antibody production assays
(Figure 5) had a different pattern from the T cell
assays. Prior to challenge on day 17, B cell
proliferation (Figure 4) and induced antibody
production (Figure 5) were similar in both
groups. At 23 days of age (4 days PC) both
parameters were depressed. At 30 days of age,
the B cell mitogen activity (Figure 4) and the
induced antibody production (Figure 5) were
higher in the treatment group. Al 56 days of
age, the B cell mitogen activity was similar in
both groups and the forced antibody production
was higher in the control group.

Results
Production Results from the growth trial are
presented in Table 1•·•. In the starter phase, the
treatment protocol improved daily gain (P<.124)
and feed efficiency (P<0.079) (Table 1•). In the
grower, finisher, and overall growth phases,
performance was not affected by treatment
(P>.10) (Tables 1•·d). Ultrasonic measurements
of 10th rib backfat thickness and loin eye area at
240 lbs. were unaffected by treatment (P>.10)
(Table 1°).
Clinical Signs: The temperatures of the
treated pigs were not significantly different from
the control group from day 1 to day 15 PC)
(Figure 1). The temperatures of the treated pigs
were in the normal range throughout the trial
(Figure 1).
From Day 6 to Day 15, the
temperatures of the treated pigs were lower than
the control. The diarrhea scores were similar
between control and treatment groups. The
diarrhea was biphasic in the control group at 4-5
days PC and at 18-24 days PC. The highest
amount of diarrhea occurred at Days 18-22 PC
(Figure 2).

Discussion

Microbiology: No rotavirus was identified
prior to challenge (Table 2). Rotavirus was
identified at Day 3 PC in both control and treated
pigs. Rotavirus was also identified at Day 10
and Day 16 PC (Table 2) in the control pigs.
Hemolytic E.coli was isolated from 1 treatment
pen prior to beginning the study (Table 3). Tests
are under way to determine the serotype.
Hemolytic E.coli at moderate levels were
isolated at Days 16 and 24 PC. No hemolytic
E.coli was isolated from the control pigs prior to
the study.
Hemolytic E.coli was present in
through out the trial in the control group
(Table 3). Serotyping of the E.coli established
that the challenge was 0111 but subsequent
isolations throughout the trial were negative for
0111.

The production results indicate again an
early advantage in rate of gain and feed
efficiency in the treatment group (Table 1•).
However by the end of the trial the two groups
were similar in these parameters (Table 1'").
Data from this trial indicate that this MMEW
protocol improves nursery performance but
compensatory performance masks those
benefits in the grower and finisher phases.
These results may represent what would happen
under field conditions following removal from
water antibiotic therapy. One of the main design
issues is that the control and treatment animals
were housed in adjacent pens throughout the
trial.
The treated pigs could have become
infected after the end of the treatment resulting
in similar production results at the end of the
study. In the future, strict segregation should be
used to determine the long-term effect of this
antibiotic therapy.

Serology: There was no serological
response to the M. hyopneumoniae vaccination
in the treated pigs and a very small response
(1/10) of the control pigs (Table 4). Three of the
control pigs had passive M. hyopneumoniae

Clinical scores were similar for both groups.
The initial design called for monitoring
temperatures for 14 days. The data indicates
that temperatures were on the rise and with the
occurrence of diarrhea at 18 days temperatures

132

vaccine, Oxford Laboratories) was a different
3
product from that used in the previous trial
(Respisure, Pfizer). The manufacturer of the
vaccine was the same company that performed
the M. hyopneumoniae ELISA test. Both the
efficacy of the vaccine and the sensitivity of the
ELISA testing method are questionable and
neither the vaccine nor the tests are available.

should be monitored concurrently with diarrhea.
The diarrhea scores indicate that the treated
pigs were partially protected from the initial
diarrheal phase at 4-5 days PC. Duration and
severity of the second phase was similar
between the two groups.
Again the
contamination and infection of the treated pigs
by the adjacent control pigs following end of
antibiotic therapy could have played a factor in
the resulting second diarrheal phase.
The
immune response to diarrheal disease in the
control animals was not effective in preventing
the second diarrheal phase.

The immunological data was similar to that
seen in our two previous studies 2 ·3 •6 • There was
a decreased T cell response indicating a lower
inflammatory response.
This decreased
inflammatory response has a sparing effect that
allows increased growth in the treated pigs. The
antibody capacity and production of the treated
animals as measured by B cell mitogen activity
and forced immunoglobulin should allow them to
respond to a challenge.

The microbiological data was interesting in
this trial. Rotavirus recovery was much lower in
the treated pigs. The sensitivity of the electron
microscopy detection is 105 particles/ml. The
decreased rotavirus detection indicates lower
replication of rotavirus in the treated pigs. E.coli
detection was also lower with no organisms
detected 3 days PC indicating that the treatment
reduced the load of E.coli. Subsequently the
levels of E.coli recovery during the second
diarrheal phase were similar between the two
groups. The challenge 0111 serotype could not
be recovered after the initial infection. We have
no explanation for these phenomena.

Conclusions
These results indicate an increase in daily
gain and feed efficiency with pigs treated with an
oral antibiotic regiment. The E.co/i-rotavirus
challenge model indicated an advantage to the
treated pigs with a lower fever response
increased clearance of E.coli and rotavirus and
decreased T cell activation. These decreased
physiological and immunological responses and
higher pathogen clearance are all factors that
could result in the increased production
parameters
in
the
treatment
group.

The serological data in this experiment was
not useful. There was a single control pig that
responded to the M. hyopneumoniae vaccine.
The vaccine used in this trial (M. hyopneumonia
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TABLE 1". WEANING PERFORMANCE (STARTER PHASE-DAYS 17-61, 10-46
LBS.
Control
0.756
1.418
1.900

Daily gain, lbs.
Daily feed. lbs.
Feed/gain

Treatment
0.827
1.440
1.742

P value
0.124
0.542
0.079

TABLE 1b. PERFORMANCE (GROWER PHASE-DAYS 62-105, 46-118 LBS.)
Control
1.647
4.083
2.489

Daily gain, lbs.
Daily feed lbs.
Feed/gain

Treatment
1.689
4.248
2.511

Pvalue
0.465
0.258
0.717

TABLE 1°. PERFORMANCE (FINISHING PHASE-DAYS 106-160, 118-234 LBS.)
Control
Daily gain, lbs.
Daily feed. lbs.
Feed/gain

Treatment

2.052
6.356
3.116

2.026
6.377
3.153

P value
0.762
0.911
0.595

TABLE 1d. OVERALL PERFORMANCE (DAYS 17-160, 10-234 LBS.)
Control
1.529
4.154
2.730

Daily gain, lbs.
Daily feed. lbs.
Feed/gain

Treatment
1.554
4.222
2.717

P value
0.570
0.435
0.793

TABLE 1°. CARCASS PERFORMANCE (234 LBS.)
10th Rib Fat Thickness, in.
Loin Eye Area, sg. in.

Control
0.849
5.175

Treatment
0.849
5.076

P value
0.999
0.405

TABLE 2. ROTAVIRUS DETECTION IN PIGS
Days
Daya
Day3
Day10
Control
neg.
pas.
pas.
Treated
neg.
pas.
neg.
pas-virus ·detected in fecal samples
neg-no virus was detected in fecal samples

134

Post Challenge
Day 16
Day24
pas.
.neg.
neg.
neg.

Day28
neg.
neg.

Day35
neg.
neg.

TABLE 3. E.coli DETECTION IN PIGS
DayO
Day3
Control
1.1
0
Treated
0.1
0
0-no hemolytic E.coli
1-few hemolytic E.coli
2-moderate hemolytic E.coli
3-many hemolytic E.coli

Days Post Challenge
Day 10
Day24
Day 16
1.3
1.1
2.3
0.9
1.6
2.0

Day28
1.3
0

Day35
0.1
0.4

TABLE 4. SEROLOGICAL RESPONSE (LOG10) TO Mycoplasma hyopneumoniae
(NUMBER OF PIGS SEROPOSITIVE/TOTAL NUMBER OF PIGS TESTED)
Days of age
Day10
Day56

Treatment
0 (0/10)
0 (0/10)
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Control
0.77±1.25 (3/10)
0.32+1.01 (1/10)

